Literature DB >> 26179749

Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma?

M Grimm1, B Calgéer2, P Teriete3, T Biegner4, A Munz2, S Reinert2.   

Abstract

PURPOSE: Thiamine-dependent enzymes (TDEs) linking glycolysis with the tricarboxylic acid cycle (TCA) pyruvate dehydrogenase (PDH), of the pentose phosphate pathway transketolases (TKTs), the TCA alpha-ketoglutarate deydrogenase (KGDH)/2-oxoglutarate dehydrogenase (OGDH) complex, and the amino acid catabolism branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex are crucial factors for tumor metabolism. The expression of these enzymes has not been analyzed for carcinogenesis of oral squamous cell carcinoma (OSCC) with special focus on new targeted metabolic therapies as yet.
METHODS: TDEs PDH, KGDH (OGDH), and BCKDH were analyzed in normal oral mucosa (n = 14), oral precursor lesions (simple hyperplasia, n = 21; squamous intraepithelial neoplasia, SIN I-III, n = 35), and OSCC specimen (n = 46) by immunohistochemistry and western blot (WB) analysis in OSCC tumor cell lines.
RESULTS: Although the total numbers of PDH and KGDH (OGDH) positive samples decreased in OSCC, both enzymes were significantly overexpressed in the carcinogenesis of OSCC compared with normal tissue. BCKDH has been demonstrated to be significantly overexpressed in the carcinogenesis of OSCC. Specificity of the antibodies was confirmed by WB analysis.
CONCLUSIONS: This is the first study showing increased expression of TDEs in OSCC. Metabolic targeting of TDEs (including TKTs) by antagonistic compounds like oxythiamine or oxybenfothiamine may be a useful strategy to sensitize cancer cells to common OSCC cancer therapies.

Entities:  

Keywords:  Oral squamous cell carcinoma; Oxybenfothiamine; Targeted therapy; Thiamine-dependent enzymes; Tumor metabolism

Mesh:

Substances:

Year:  2015        PMID: 26179749     DOI: 10.1007/s12094-015-1352-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  58 in total

Review 1.  The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases.

Authors:  Peter W Stacpoole
Journal:  Aging Cell       Date:  2012-04-04       Impact factor: 9.304

Review 2.  Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment I.

Authors:  R A Walker
Journal:  Histopathology       Date:  2006-10       Impact factor: 5.087

Review 3.  Thiamin deficiency: a possible major cause of some tumors? (review).

Authors:  Benjamin Y Lee; Krishna Yanamandra; Joseph A Bocchini
Journal:  Oncol Rep       Date:  2005-12       Impact factor: 3.906

Review 4.  Population thiamine status and varying cancer rates between western, Asian and African countries.

Authors:  L G Boros
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

Review 5.  Mechanisms responsible for regulation of branched-chain amino acid catabolism.

Authors:  Robert A Harris; Mandar Joshi; Nam Ho Jeoung
Journal:  Biochem Biophys Res Commun       Date:  2004-01-09       Impact factor: 3.575

Review 6.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

7.  Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma.

Authors:  Martin Grimm; Dorothea Alexander; Adelheid Munz; Juergen Hoffmann; Siegmar Reinert
Journal:  Clin Exp Metastasis       Date:  2012-11-25       Impact factor: 5.150

8.  TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization.

Authors:  Wenyue Sun; Yan Liu; Chad A Glazer; Chunbo Shao; Sheetal Bhan; Semra Demokan; Ming Zhao; Michelle A Rudek; Patrick K Ha; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

9.  Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.

Authors:  Atsushi Hamabe; Hirofumi Yamamoto; Masamitsu Konno; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Tsunekazu Mizushima; Naohiro Nishida; Koichi Kawamoto; Jun Koseki; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Cancer Sci       Date:  2014-09-16       Impact factor: 6.716

10.  Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?

Authors:  Martin Grimm; Marcel Cetindis; Max Lehmann; Thorsten Biegner; Adelheid Munz; Peter Teriete; Wiebke Kraut; Siegmar Reinert
Journal:  J Transl Med       Date:  2014-07-21       Impact factor: 5.531

View more
  5 in total

1.  Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.

Authors:  Martin Grimm; Johan Rieth; Sebastian Hoefert; Michael Krimmel; Sven Rieth; Peter Teriete; Susanne Kluba; Thorsten Biegner; Adelheid Munz; Siegmar Reinert
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

Review 2.  Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease.

Authors:  Elizabeth A Rowland; Caroline K Snowden; Ileana M Cristea
Journal:  Curr Opin Chem Biol       Date:  2017-11-21       Impact factor: 8.822

3.  A dose- and time-dependent effect of oxythiamine on cell growth inhibition in non-small cell lung cancer.

Authors:  Lin Bai; Hui-Li Zhu
Journal:  Cogn Neurodyn       Date:  2021-11-09       Impact factor: 3.473

4.  Estrogen and Progesterone hormone receptor expression in oral cavity cancer.

Authors:  M Grimm; T Biegner; P Teriete; S Hoefert; M Krimmel; A Munz; S Reinert
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01

5.  OGDH promotes the progression of gastric cancer by regulating mitochondrial bioenergetics and Wnt/β-catenin signal pathway.

Authors:  Xin Lu; Nan Wu; Wanli Yang; Jia Sun; Kemin Yan; Jing Wu
Journal:  Onco Targets Ther       Date:  2019-09-12       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.